CIK: 1592286 - Address: C/o Oxford Immunotec Global Plc, 94C Innovation Drive, Abingdon, Oxfordshire, X0 OX14 4RZ
18 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret1151104001
S%wins6040602546

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/3/19 16:01
10/1/19
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS-48616.210-30-9295D
9/25/19 16:00
9/23/19
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.m-1,65916.590-100-24325D
8/20/19 16:32
8/16/19
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS-13913.860-10-2425D
4/3/19 16:30
4/1/19
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-17716.680-11-2435D
2/20/19 16:30
2/19/19
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS-17016.990-10-2413D
1/11/19 16:35
1/10/19
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS-14914.910-10-2423D
10/3/18 16:30
10/1/18
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.m-33416.710-20-4433D
9/27/18 16:30
9/25/18
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-1,58618.420-86-16453D
9/10/18 16:30
9/7/18
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-59814.950-40-8485D
10/4/17 16:30
10/2/17
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-92316.780-55-11462D
7/10/17 16:30
7/6/17
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-43315.940-27-6462D
7/7/17 16:30
7/5/17
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-54416.580-33-7462D
6/29/17 16:30
6/28/17
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-48216.060-30-6462D
4/5/17 16:29
4/3/17
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-46315.432-30-6462D1842194152-1-101-7
2/7/17 18:29
2/6/17
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-33413.361-25-5438D33438-4-100-1-111125
12/20/16 16:30
12/16/16
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-10615.071-7-2443D242568244112-1-1-103
12/7/16 17:11
12/5/16
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.d-1715.001-10443D251265361532-15666
12/5/16 16:31
12/1/16
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticWrighton-Smith PeterX0DOCEOS.dm-92715.001-62-12443D1518644015421-1000

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact